VS

Vinod Shriramji Dagdiya

Active Director Director DIN 01520472
DIN 01520472 First appointment Jul 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jul 2007
Shareholding value •••• Premium profile

About Vinod Shriramji Dagdiya

Data last updated:

Vinod Shriramji Dagdiya is a Director at Milton Medicare Private Limited (since 2012), Director at Inox Bioscience Private Limited (since 2021) and Designated Partner at Medorus Healthcare Llp (since 2025), and holds 1 more current directorship. The companies operate in Pharma and Automotive. The 2 current companies with reported revenue have a combined latest revenue of ₹165 Cr; the largest is Milton Medicare Private Limited at ₹143 Cr (FY 2025). Earlier, Vinod Shriramji Dagdiya was a Director at Shiv Sharda Auto Lines Private Limited (2007–2012) and Director at 9M Pharmalogic Private Limited (2019–2020).

DIN 01520472
Primary Designation Director
Industry Pharma
First Appointment 18 Jul 2007
Oldest Company Age 14 yrs
Largest company Milton Medicare Private Limited · ₹143 Cr (FY 2025)
Combined revenue ₹165 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Milton Medicare Private Limited U74120MH2012PTC226015
Director12 Jan 20122012₹143 Cr (FY 2025)Active
Inox Bioscience Private Limited U51909PN2021PTC198747
Director19 Feb 20212021₹21.28 Cr (FY 2025)Active
Designated Partner23 Jan 20252025Active
Designated Partner18 Aug 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jul 20072007₹18.97 Cr (FY 2025)Active
9M Pharmalogic Private Limited U74999PN2019PTC181930
Director05 Feb 20192019₹10.87 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Vinod Shriramji Dagdiya

Directorship timeline

Open interactive timeline →
Inorbit Biotech Llp
Inox Bioscience Private Limited
Milton Medicare Private Limited
Medorus Healthcare Llp
Premium access

Shareholding and investment profile for Vinod Shriramji Dagdiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vinod Shriramji Dagdiya

Vinod Shriramji Dagdiya currently holds 4 directorships: Milton Medicare Private Limited (Director, since 12 Jan 2012, revenue ₹143 Cr (FY 2025)); Inox Bioscience Private Limited (Director, since 19 Feb 2021, revenue ₹21.28 Cr (FY 2025)); Medorus Healthcare Llp (Designated Partner, since 23 Jan 2025); Inorbit Biotech Llp (Designated Partner, since 18 Aug 2021).

Vinod Shriramji Dagdiya was first appointed on 18 Jul 2007 as Director at Shiv Sharda Auto Lines Private Limited. The most recent appointment on record is 23 Jan 2025 at Medorus Healthcare Llp.

The 2 current companies of Vinod Shriramji Dagdiya that report revenue have a combined latest revenue of ₹165 Cr: Milton Medicare Private Limited ₹143 Cr (FY 2025); Inox Bioscience Private Limited ₹21.28 Cr (FY 2025).

Vinod Shriramji Dagdiya held 2 earlier board appointments: Shiv Sharda Auto Lines Private Limited (Director, 18 Jul 2007 to 20 Jan 2012); 9M Pharmalogic Private Limited (Director, 05 Feb 2019 to 10 Dec 2020).

The current boards of Vinod Shriramji Dagdiya's companies include Anil Chhaganlal Jain (Milton Medicare Private Limited), Mahesh Kamlakar Pawar (Inox Bioscience Private Limited), Ravikant Dineshprasad Singh (Medorus Healthcare Llp), Sahil Rajesh Dagdiya (Medorus Healthcare Llp), Rushikesh Pandurang Deshmukh (Inorbit Biotech Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available